Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Type Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01828086
What this trial is testing

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 95
Large-scale testing (Phase 3)Study completedNCT01139580
What this trial is testing

The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 363
Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Post-approval studies (Phase 4)Ended earlyNCT00924950
What this trial is testing

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis Vulgaris
University of California, San Francisco 35
Early research (Phase 1)Study completedNCT02397382
What this trial is testing

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 16
Not applicableStudy completedNCT02107482
What this trial is testing

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 21
Large-scale testing (Phase 3)Study completedNCT01358578
What this trial is testing

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 1,306
Testing effectiveness (Phase 2)Study completedNCT00604682
What this trial is testing

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 19
Not applicableLooking for participantsNCT07021495
What this trial is testing

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center 840
Testing effectiveness (Phase 2)Study completedNCT00236119
What this trial is testing

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

Who this might be right for
Psoriasis
Cephalon 46
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Post-approval studies (Phase 4)UnknownNCT02248792
What this trial is testing

Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.

Who this might be right for
Severe Plaque Type Psoriasis
Narayana Medical College & Hospital 50
Early research (Phase 1)Study completedNCT03399526
What this trial is testing

1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

Who this might be right for
Psoriasis
Bayer 24
Testing effectiveness (Phase 2)Looking for participantsNCT07410793
What this trial is testing

Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.

Who this might be right for
Plaque Type Psorisis
Mae Fah Luang University 28
Testing effectiveness (Phase 2)Study completedNCT04911751
What this trial is testing

Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

Who this might be right for
Psoriatic Plaque
KoBioLabs 80
Testing effectiveness (Phase 2)Study completedNCT03000075
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 182
Early research (Phase 1)Study completedNCT01646567
What this trial is testing

SHP-141C in Plaque Type Psoriasis

Who this might be right for
Plaque Type Psoriasis
TetraLogic Pharmaceuticals 14
Post-approval studies (Phase 4)Study completedNCT00852761
What this trial is testing

Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Who this might be right for
Plaque-Type Psoriasis
Stiefel, a GSK Company 34
Testing effectiveness (Phase 2)Study completedNCT02622386
What this trial is testing

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of Michigan 23
Large-scale testing (Phase 3)Study completedNCT01891864
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

Who this might be right for
Chronic Stable Plaque Psoriasis
Sandoz 531
Next Page